These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2105706)

  • 1. Fluoxetine and side effects.
    Baldessarini RJ; Marsh E
    Arch Gen Psychiatry; 1990 Feb; 47(2):191-2. PubMed ID: 2105706
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS
    Brain Res; 1992 May; 579(1):152-6. PubMed ID: 1623401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-dopa administration on the serotonergic system in rat brain: correlation between levels of L-dopa accumulated in the brain and depletion of serotonin and tryptophan.
    Algeri S; Cerletti C
    Eur J Pharmacol; 1974 Jul; 27(2):191-7. PubMed ID: 4851789
    [No Abstract]   [Full Text] [Related]  

  • 4. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms.
    Caccia S; Bizzi A; Coltro G; Fracasso C; Frittoli E; Mennini T; Garattini S
    J Pharm Pharmacol; 1992 Mar; 44(3):250-4. PubMed ID: 1354734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. II. Neurochemical alterations and responses to pharmacological treatments.
    Pletnikov MV; Rubin SA; Vogel MW; Moran TH; Carbone KM
    Brain Res; 2002 Jul; 944(1-2):108-23. PubMed ID: 12106671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high performance liquid chromatography method for measuring brain dihydroxyphenylalanine levels and dopamine synthesis rates.
    Tabakoff B; Black RF
    J Neurochem; 1980 Jun; 34(6):1707-11. PubMed ID: 6770047
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140).
    Fuller RW; Perry KW; Molloy BB
    Life Sci; 1974 Sep; 15(6):1161-71. PubMed ID: 4550008
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxetine-dopaminergic interaction data.
    Beasley CM
    J Clin Psychiatry; 1994 Feb; 55(2):77-9. PubMed ID: 8077159
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats.
    Fuller RW; Snoddy HD
    Pharmacol Biochem Behav; 1986 Feb; 24(2):281-4. PubMed ID: 3485293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine-induced attenuation of amphetamine self-administration in rats.
    Yu DS; Smith FL; Smith DG; Lyness WH
    Life Sci; 1986 Oct; 39(15):1383-8. PubMed ID: 3489876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding.
    Cunningham KA; Paris JM; Goeders NE
    Synapse; 1992 Jun; 11(2):112-23. PubMed ID: 1385662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorpromazine-induced accumulation of pyridoxal-5'-phosphate and activation of the decarboxylase of aromatic amino acids in rat brain.
    Gey KF; Burkard WP
    Ann N Y Acad Sci; 1969 Sep; 166(1):213-24. PubMed ID: 5308031
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain amines and temperature regulation.
    Reid WD; Volicer L; Smookler H; Beaven MA; Brodie BB
    Pharmacology; 1968; 1(6):329-44. PubMed ID: 5710608
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletions of central norepinephrine by intraventricular xylamine in rats.
    Geyer MA; Gordon J; Adams LM
    Eur J Pharmacol; 1984 Apr; 100(2):227-31. PubMed ID: 6203760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum.
    Perry KW; Fuller RW
    Life Sci; 1992; 50(22):1683-90. PubMed ID: 1375306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous anesthetics on brain monoamines in the rat.
    Sung YF; Frederickson EL; Holtzman SG
    Anesthesiology; 1973 Nov; 39(5):478-87. PubMed ID: 4746053
    [No Abstract]   [Full Text] [Related]  

  • 20. Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.
    Bartholini G; Constantinidis J; Tissot R; Pletscher A
    Biochem Pharmacol; 1971 Jun; 20(6):1243-7. PubMed ID: 5315769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.